Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury
Top Cited Papers
- 1 December 2001
- journal article
- Published by Elsevier BV in Kidney International
- Vol. 60 (6), 2118-2128
- https://doi.org/10.1046/j.1523-1755.2001.00043.x
Abstract
Acute renal failure (ARF) is caused by ischemic and nephrotoxic insults acting alone or in combination. Anti-inflammatory agents have been shown to decrease renal ischemia-reperfusion and cisplatin-induced injury and leukocyte infiltration. Interleukin-10 (IL-10) is a potent anti-inflammatory cytokine that inhibits inflammatory and cytotoxic pathways implicated in acute renal injury. Therefore, we sought to determine if IL-10 inhibits acute renal injury. The effects of IL-10 were studied in mice following cisplatin administration and bilateral renal ischemia-reperfusion, in a rat model of renal transplantation, and in cultured mouse cortical tubule cells. IL-10 significantly decreased renal injury following cisplatin administration and following renal ischemia/reperfusion. Delay of IL-10 treatment for one hour after cisplatin also significantly inhibited renal damage. IL-10 and alpha-melanocyte stimulating hormone (alpha-MSH) increased recovery following transplantation of a kidney subjected to warm ischemia. To explore the mechanism of action of IL-10, its effects were measured on mediators of leukocyte trafficking and inducible nitric oxide synthase (NOS-II). IL-10 inhibited cisplatin and ischemia-induced increases in mRNA for tumor necrosis factor-alpha (TNF-alpha), intercellular adhesion molecule-1 (ICAM-1), and NOS-II. IL-10 also inhibited staining for markers of apoptosis and cell cycle activity following cisplatin administration, and nitric oxide production in cultured mouse cortical tubules. IL-10 protects against renal ischemic and cisplatin-induced injury. IL-10 may act, in part, by inhibiting the maladaptive activation of genes that cause leukocyte activation and adhesion, and induction of iNOS.Keywords
This publication has 64 references indexed in Scilit:
- α‐MSH decreases apoptosis in ischaemic acute renal failure in rats: possible mechanism of this beneficial effectNephrology Dialysis Transplantation, 2001
- PREVENTION OF CISPLATIN-INDUCED NEPHROTOXICITY BY METHIMAZOLEPharmacological Research, 2000
- Prevention of Nephrotoxicity of Cisplatin by Repeated Oral Administration of Ebselen in RatsThe Tohoku Journal of Experimental Medicine, 2000
- α-Melanocyte-stimulating hormone inhibits renal injury in the absence of neutrophilsKidney International, 1998
- Treatment of acute renal failureKidney International, 1998
- Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance.JCI Insight, 1995
- Antibodies to ICAM-1 Protect Kidneys in Severe Ischemic Reperfusion InjuryBiochemical and Biophysical Research Communications, 1995
- Immunosuppressive and Anti-inflammatory Properties of Interleukin 10Annals of Medicine, 1995
- Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-γ in murine macrophagesBiochemical and Biophysical Research Communications, 1992
- Protective action of glycine in cisplatin nephrotoxicityKidney International, 1991